Company

Travere Therapeutics

Travere Therapeutics is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.

Latest on Travere Therapeutics

  • 13F: Lisanti Capital Growth Llc holds Travere Therapeutics ($7M)
  • 13F: Jw Asset Management Llc holds Travere Therapeutics ($2M)

Connections

2 entities linked to Travere Therapeutics across the news graph.